BAX – Baxter International Inc.
Baxter International Inc.BAX
$28.89Name : Baxter International Inc.
Sector : Healthcare
Industry: Medical Instruments & Supplies
Mark. Cap: $14,818,373,632.00
EPSttm : -0.64
Baxter International Inc.
$28.89
3.85%$1.07Float Short %
3.57
Margin Of Safety %
38
Put/Call OI Ratio
0.38
EPS Next Q Diff
0.03
EPS Last/This Y
3.76
EPS This/Next Y
0.24
Price
28.89
Target Price
37.77
Analyst Recom
2.58
Performance Q
-6.66
Relative Volume
1.1
Beta
0.69
Ticker: BAX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-20 | BAX | 33.43 | 0.51 | 0.13 | 69026 |
| 2025-03-21 | BAX | 33.2 | 0.47 | 0.46 | 72573 |
| 2025-03-24 | BAX | 33.6 | 0.39 | 0.03 | 64218 |
| 2025-03-25 | BAX | 32.94 | 0.37 | 3.61 | 66650 |
| 2025-03-26 | BAX | 33.38 | 0.38 | 0.42 | 67290 |
| 2025-03-27 | BAX | 33.71 | 0.38 | 0.82 | 67373 |
| 2025-03-28 | BAX | 33.74 | 0.38 | 2.07 | 67396 |
| 2025-03-31 | BAX | 34.23 | 0.41 | 3.46 | 66638 |
| 2025-04-01 | BAX | 34.03 | 0.47 | 0.33 | 69783 |
| 2025-04-02 | BAX | 33.63 | 0.44 | 0.60 | 68597 |
| 2025-04-03 | BAX | 31.35 | 0.44 | 0.44 | 68727 |
| 2025-04-04 | BAX | 28.8 | 0.44 | 0.04 | 69572 |
| 2025-04-07 | BAX | 28.62 | 0.40 | 0.27 | 77362 |
| 2025-04-08 | BAX | 27.97 | 0.40 | 1.40 | 77773 |
| 2025-04-09 | BAX | 30.78 | 0.40 | 0.14 | 78756 |
| 2025-04-10 | BAX | 28.13 | 0.36 | 0.08 | 89110 |
| 2025-04-11 | BAX | 27.83 | 0.40 | 0.38 | 83839 |
| 2025-04-14 | BAX | 28.38 | 0.40 | 0.36 | 82959 |
| 2025-04-15 | BAX | 27.81 | 0.39 | 1.91 | 83016 |
| 2025-04-16 | BAX | 27.83 | 0.39 | 0.44 | 83068 |
| 2025-04-17 | BAX | 28.9 | 0.38 | 0.20 | 83468 |
| 2025-04-18 | BAX | 28.89 | 0.38 | 0.20 | 83468 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-20 | BAX | 33.44 | -25.8 | 1349.3 | 2.49 |
| 2025-03-21 | BAX | 33.22 | -25.8 | 1360.4 | 2.49 |
| 2025-03-24 | BAX | 33.60 | -25.8 | 1377.1 | 2.49 |
| 2025-03-25 | BAX | 32.94 | -25.8 | 1348.9 | 2.49 |
| 2025-03-26 | BAX | 33.36 | -25.8 | 1377.4 | 2.49 |
| 2025-03-27 | BAX | 33.71 | -25.8 | 1371.2 | 2.49 |
| 2025-03-28 | BAX | 33.75 | -25.8 | 1367.3 | 2.49 |
| 2025-03-31 | BAX | 34.22 | -25.7 | 1378.3 | 2.49 |
| 2025-04-01 | BAX | 34.02 | -25.7 | 1360.5 | 2.49 |
| 2025-04-02 | BAX | 33.65 | -25.7 | 1356.3 | 2.49 |
| 2025-04-03 | BAX | 31.34 | -25.7 | 1305.3 | 2.49 |
| 2025-04-04 | BAX | 28.80 | -25.7 | 1296.0 | 2.49 |
| 2025-04-07 | BAX | 28.63 | -25.7 | 1361.4 | 2.49 |
| 2025-04-08 | BAX | 27.97 | -25.7 | 1346.6 | 2.49 |
| 2025-04-09 | BAX | 30.79 | -25.7 | 1448.5 | 2.49 |
| 2025-04-10 | BAX | 28.14 | -25.7 | 1293.6 | 2.49 |
| 2025-04-11 | BAX | 27.83 | -25.7 | 1356.8 | 2.49 |
| 2025-04-14 | BAX | 28.38 | -25.7 | 1381.8 | 2.49 |
| 2025-04-15 | BAX | 27.80 | -25.7 | 1349.1 | 2.49 |
| 2025-04-16 | BAX | 27.83 | -25.7 | 1366.9 | 2.49 |
| 2025-04-17 | BAX | 28.89 | -25.7 | 1397.4 | 2.49 |
| 2025-04-18 | BAX | 28.89 | -25.7 | 1366.0 | 2.49 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-20 | BAX | 0.00 | 1.83 | 4.14 |
| 2025-03-21 | BAX | 0.00 | 1.83 | 4.14 |
| 2025-03-24 | BAX | 0.00 | 1.83 | 4.14 |
| 2025-03-25 | BAX | 0.00 | 1.83 | 4.14 |
| 2025-03-26 | BAX | 0.00 | 1.83 | 3.61 |
| 2025-03-27 | BAX | 0.00 | 1.83 | 3.61 |
| 2025-03-28 | BAX | 0.00 | 1.83 | 3.61 |
| 2025-03-31 | BAX | 0.00 | 1.49 | 3.60 |
| 2025-04-01 | BAX | 0.00 | 1.49 | 3.60 |
| 2025-04-02 | BAX | 0.00 | 1.49 | 3.60 |
| 2025-04-03 | BAX | 0.00 | 1.49 | 3.60 |
| 2025-04-04 | BAX | 0.00 | 1.49 | 3.60 |
| 2025-04-07 | BAX | 0.00 | 1.34 | 3.60 |
| 2025-04-08 | BAX | 0.00 | 1.34 | 3.60 |
| 2025-04-09 | BAX | 0.00 | 1.34 | 3.60 |
| 2025-04-10 | BAX | 0.00 | 1.34 | 3.57 |
| 2025-04-11 | BAX | 0.00 | 1.34 | 3.57 |
| 2025-04-14 | BAX | 0.00 | 1.28 | 3.57 |
| 2025-04-15 | BAX | 0.00 | 1.28 | 3.57 |
| 2025-04-16 | BAX | 0.00 | 1.28 | 3.57 |
| 2025-04-17 | BAX | 0.00 | 1.28 | 3.57 |
| 2025-04-18 | BAX | 0.00 | 1.28 | 3.57 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.58
Avg. EPS Est. Current Quarter
0.48
Avg. EPS Est. Next Quarter
0.61
Insider Transactions
Institutional Transactions
1.28
Beta
0.69
Average Sales Estimate Current Quarter
2587
Average Sales Estimate Next Quarter
2833
Fair Value
39.86
Quality Score
46
Growth Score
50
Sentiment Score
34
Actual DrawDown %
69.7
Max Drawdown 5-Year %
-70.5
Target Price
37.77
P/E
Forward P/E
10.59
PEG
P/S
1.15
P/B
2.12
P/Free Cash Flow
25.86
EPS
-1.27
Average EPS Est. Cur. Y
2.49
EPS Next Y. (Est.)
2.73
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-5.05
Relative Volume
1.1
Return on Equity vs Sector %
-29.3
Return on Equity vs Industry %
-17.8
EPS 1 7Days Diff
EPS 1 30Days Diff
0.01
EBIT Estimation
1366
Baxter International Inc.Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 38000
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; administrative sets; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It has an agreement with Celerity Pharmaceuticals, LLC to develop acute care generic injectable premix and oncolytic products. The company operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
stock quote shares BAX – Baxter International Inc. Stock Price stock today
news today BAX – Baxter International Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch BAX – Baxter International Inc. yahoo finance google finance
stock history BAX – Baxter International Inc. invest stock market
stock prices BAX premarket after hours
ticker BAX fair value insiders trading